BR112015018077A2 - dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato - Google Patents

dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato

Info

Publication number
BR112015018077A2
BR112015018077A2 BR112015018077A BR112015018077A BR112015018077A2 BR 112015018077 A2 BR112015018077 A2 BR 112015018077A2 BR 112015018077 A BR112015018077 A BR 112015018077A BR 112015018077 A BR112015018077 A BR 112015018077A BR 112015018077 A2 BR112015018077 A2 BR 112015018077A2
Authority
BR
Brazil
Prior art keywords
contact path
blood collection
collection devices
inhibitor
additive
Prior art date
Application number
BR112015018077A
Other languages
English (en)
Inventor
L Sinquett Frank
A Moskowitz Keith
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of BR112015018077A2 publication Critical patent/BR112015018077A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0236Mechanical aspects
    • A01N1/0263Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021Test tubes specially adapted for centrifugation purposes
    • B01L3/50215Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1406Septums, pierceable membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/04Closures and closing means
    • B01L2300/041Connecting closures to device or container
    • B01L2300/042Caps; Plugs
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/04Closures and closing means
    • B01L2300/041Connecting closures to device or container
    • B01L2300/044Connecting closures to device or container pierceable, e.g. films, membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Clinical Laboratory Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo “dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato” a presente invenção se refere a dispositivos para a coleta de sangue que contêm um anticoagulante e um aditivo que retarda a coagulação por inibir o trajeto de contato para a geração de trombina. o aditivo é um aditivo inibidor de trajeto de contato de coagulação que é pelo menos um de um inibidor de fator xi, um inibidor de fator xii, um inibidor de calicreína e combinações dos mesmos, cada um em uma quantidade eficaz para mediar ou suprimir o trajeto de contato para a geração de trombina. métodos de produção e de uso dos dispositivos, e kits que contêm os dis-positivos, são também proporcionados.
BR112015018077A 2013-02-01 2014-01-31 dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato BR112015018077A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361759742P 2013-02-01 2013-02-01
PCT/US2014/014089 WO2014121041A1 (en) 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives

Publications (1)

Publication Number Publication Date
BR112015018077A2 true BR112015018077A2 (pt) 2017-07-18

Family

ID=51259520

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015018077A BR112015018077A2 (pt) 2013-02-01 2014-01-31 dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato

Country Status (12)

Country Link
US (1) US20140220552A1 (pt)
EP (1) EP2950718A4 (pt)
JP (1) JP2016505159A (pt)
KR (1) KR20150141940A (pt)
CN (1) CN105188535A (pt)
AU (1) AU2014212194A1 (pt)
BR (1) BR112015018077A2 (pt)
CA (1) CA2899594A1 (pt)
MX (1) MX2015009914A (pt)
RU (1) RU2015136025A (pt)
SG (1) SG11201505978PA (pt)
WO (1) WO2014121041A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102523810B1 (ko) 2013-01-20 2023-04-21 다케다 파머수티컬 컴패니 리미티드 브래디키닌 매개 장애의 평가 및 치료
JP6757252B2 (ja) 2013-10-21 2020-09-16 ダイアックス コーポレーション 血漿カリクレイン系バイオマーカーを決定するためのアッセイ
EP3294133B1 (en) * 2015-05-14 2019-09-04 General Electric Company Method and kit for separation and collection of plasma
JP6907188B2 (ja) 2015-08-13 2021-07-21 ダイアックス コーポレーション 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管
EP4354146A3 (en) * 2015-10-19 2024-06-05 Takeda Pharmaceutical Company Limited Immunoassay for the detection of cleaved high molecular weight kininogen
WO2017119508A1 (ja) * 2016-01-07 2017-07-13 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69919702T2 (de) * 1998-06-08 2005-09-15 The University Of Vermont And State Agricultural College Verfahren zur Bestimmung der Blutgerinnung in Plasma
US20030064414A1 (en) * 2001-03-30 2003-04-03 Benecky Michael J. Rapid assessment of coagulation activity in whole blood
WO2003097237A2 (en) * 2002-05-13 2003-11-27 Becton, Dickinson, And Company Protease inhibitor sample collection system
CA2515576C (en) * 2003-02-13 2013-04-30 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US7235377B2 (en) * 2003-06-09 2007-06-26 The University Of Vermont And State Agriculture College Global test of the hemostatic system
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
US8236316B2 (en) * 2007-11-21 2012-08-07 Oregon Health & Science University Anti-factor XI monoclonal antibodies and methods of use thereof
CA2818522C (en) * 2010-12-02 2016-05-17 Becton, Dickinson And Company Blood collection devices containing blood stabilization agent
US9352016B2 (en) * 2011-03-09 2016-05-31 Csl Behring Gmbh Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces

Also Published As

Publication number Publication date
RU2015136025A (ru) 2017-03-06
EP2950718A4 (en) 2016-09-21
CA2899594A1 (en) 2014-08-07
MX2015009914A (es) 2015-09-25
SG11201505978PA (en) 2015-08-28
AU2014212194A1 (en) 2015-09-17
EP2950718A1 (en) 2015-12-09
CN105188535A (zh) 2015-12-23
WO2014121041A1 (en) 2014-08-07
US20140220552A1 (en) 2014-08-07
JP2016505159A (ja) 2016-02-18
KR20150141940A (ko) 2015-12-21

Similar Documents

Publication Publication Date Title
BR112015018077A2 (pt) dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
CL2018002334A1 (es) Moduladores de complementos factor b (divisional solicitud 201600606)
CR20150228A (es) Inhibidores de la tirosina-quinasa de bruton
BR112018067408A2 (pt) formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas
EA201690987A1 (ru) Низкодозовые иммуностимулирующие ингибиторы mtor и их применения
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
EA201690473A1 (ru) Комбинированный состав двух противовирусных соединений
BR112015028152A2 (pt) inibidores de acc e usos dos mesmos
BR112015029969A2 (pt) tratamento de câncer usando moduladores de isoformas quinase pi3
EA201591959A1 (ru) Ингибиторы акк и их применение
BR112015025260A2 (pt) compostos heterocíclicos fundidos como inibidores da proteína quinase
DK3294738T3 (da) Mono- og disubstituerede indolderivater som inhibitorer af replikation af denguevirus
EA201690098A1 (ru) Конденсированные трициклические соединения мочевины в качестве ингибиторов киназы raf и/или димера киназы raf
BR112015027327A2 (pt) composições e métodos para alterar a sinalização do mensageiro secundário
TR201908247T4 (tr) Sodyum glikoz birlikte taşıyıcı 1 inhibitörleri.
EA201501032A1 (ru) Фармацевтическая композиция, способы лечения и ее применения
CL2015002473A1 (es) Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida y su uso como inhibidores de la phd.
BR112014019860A8 (pt) Produtos de gipsita com aditivos de dissipação de calor de alta eficiência
DK3350163T3 (da) Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation
BR112015030385A2 (pt) inibidores de pi3 delta e gama quinase seletivos duplos
BR112018011526A2 (pt) compostos policíclicos como inibidores da tirosina quinase de bruton
EA201692204A1 (ru) Композиции и способы модулирования экспрессии фактора комплемента b
EA201690844A1 (ru) Ингибиторы gsk-3
EA201591931A1 (ru) Композиции оксабициклогептанов и оксабициклогептенов

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2500 DE 04-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.